Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361949077> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4361949077 abstract "<div>Abstract<p><b>Purpose:</b> Glioblastoma represents the malignant brain tumor that is most refractory to treatment and in which the identification of molecular target(s) is urgently required. We investigated the expression, activity, and putative pathologic role of glycogen synthase kinase 3β (GSK3β), an emerging therapeutic target for neurodegenerative diseases, in human glioblastoma.</p><p><b>Experimental Design:</b> The active fraction of GSK3β that is phosphorylated at the tyrosine 216 residue (pGSK3β<sup>Y216</sup>) was identified in glioblastoma cell lines. GSK3β activity for phosphorylating its substrate was detected in these cells by nonradioisotopic <i>in vitro</i> kinase assay.</p><p><b>Results:</b> Higher expression levels of GSK3β and pGSK3β<sup>Y216</sup> were frequently detected in glioblastomas compared with nonneoplastic brain tissues. Inhibition of GSK3β activity by escalating doses of a small-molecule inhibitor (AR-A014418) or inhibition of its expression by RNA interference induced the apoptosis and attenuated the survival and proliferation of glioblastoma cells <i>in vitro</i>. Inhibition of GSK3β was associated with increased expression of p53 and p21 in glioblastoma cells with wild-type <i>p53</i> and with decreased Rb phosphorylation and expression of cyclin-dependent kinase 6 in all glioblastoma cell lines. Administration of AR-A014418 at a low dose significantly sensitized glioblastoma cells to temozolomide and 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea, chemotherapeutic agents used in the clinical setting, as well as to ionizing radiation.</p><p><b>Conclusion:</b> These results indicate that GSK3β exerts a pathologic role by promoting the survival and proliferation of glioblastoma cells and by protecting them from apoptosis via the inactivation of p53- and/or Rb-mediated pathways. Consequently, we propose that GSK3β provides a potential therapeutic target in glioblastoma.</p></div>" @default.
- W4361949077 created "2023-04-05" @default.
- W4361949077 creator A5034771136 @default.
- W4361949077 creator A5035827582 @default.
- W4361949077 creator A5057151089 @default.
- W4361949077 creator A5058032939 @default.
- W4361949077 creator A5060081405 @default.
- W4361949077 creator A5074536720 @default.
- W4361949077 creator A5074654484 @default.
- W4361949077 creator A5075695453 @default.
- W4361949077 creator A5081923476 @default.
- W4361949077 date "2023-03-31" @default.
- W4361949077 modified "2023-10-14" @default.
- W4361949077 title "Data from Potential Therapeutic Effect of Glycogen Synthase Kinase 3β Inhibition against Human Glioblastoma" @default.
- W4361949077 doi "https://doi.org/10.1158/1078-0432.c.6517524.v1" @default.
- W4361949077 hasPublicationYear "2023" @default.
- W4361949077 type Work @default.
- W4361949077 citedByCount "0" @default.
- W4361949077 crossrefType "posted-content" @default.
- W4361949077 hasAuthorship W4361949077A5034771136 @default.
- W4361949077 hasAuthorship W4361949077A5035827582 @default.
- W4361949077 hasAuthorship W4361949077A5057151089 @default.
- W4361949077 hasAuthorship W4361949077A5058032939 @default.
- W4361949077 hasAuthorship W4361949077A5060081405 @default.
- W4361949077 hasAuthorship W4361949077A5074536720 @default.
- W4361949077 hasAuthorship W4361949077A5074654484 @default.
- W4361949077 hasAuthorship W4361949077A5075695453 @default.
- W4361949077 hasAuthorship W4361949077A5081923476 @default.
- W4361949077 hasConcept C104629339 @default.
- W4361949077 hasConcept C11960822 @default.
- W4361949077 hasConcept C153911025 @default.
- W4361949077 hasConcept C182996813 @default.
- W4361949077 hasConcept C184235292 @default.
- W4361949077 hasConcept C185592680 @default.
- W4361949077 hasConcept C190283241 @default.
- W4361949077 hasConcept C192118531 @default.
- W4361949077 hasConcept C199835354 @default.
- W4361949077 hasConcept C202751555 @default.
- W4361949077 hasConcept C29537977 @default.
- W4361949077 hasConcept C502942594 @default.
- W4361949077 hasConcept C55493867 @default.
- W4361949077 hasConcept C86803240 @default.
- W4361949077 hasConceptScore W4361949077C104629339 @default.
- W4361949077 hasConceptScore W4361949077C11960822 @default.
- W4361949077 hasConceptScore W4361949077C153911025 @default.
- W4361949077 hasConceptScore W4361949077C182996813 @default.
- W4361949077 hasConceptScore W4361949077C184235292 @default.
- W4361949077 hasConceptScore W4361949077C185592680 @default.
- W4361949077 hasConceptScore W4361949077C190283241 @default.
- W4361949077 hasConceptScore W4361949077C192118531 @default.
- W4361949077 hasConceptScore W4361949077C199835354 @default.
- W4361949077 hasConceptScore W4361949077C202751555 @default.
- W4361949077 hasConceptScore W4361949077C29537977 @default.
- W4361949077 hasConceptScore W4361949077C502942594 @default.
- W4361949077 hasConceptScore W4361949077C55493867 @default.
- W4361949077 hasConceptScore W4361949077C86803240 @default.
- W4361949077 hasLocation W43619490771 @default.
- W4361949077 hasOpenAccess W4361949077 @default.
- W4361949077 hasPrimaryLocation W43619490771 @default.
- W4361949077 hasRelatedWork W1488072553 @default.
- W4361949077 hasRelatedWork W1977449319 @default.
- W4361949077 hasRelatedWork W2018423808 @default.
- W4361949077 hasRelatedWork W2022329592 @default.
- W4361949077 hasRelatedWork W2061983713 @default.
- W4361949077 hasRelatedWork W2081695310 @default.
- W4361949077 hasRelatedWork W2082905363 @default.
- W4361949077 hasRelatedWork W2089586561 @default.
- W4361949077 hasRelatedWork W2103711478 @default.
- W4361949077 hasRelatedWork W3021423515 @default.
- W4361949077 isParatext "false" @default.
- W4361949077 isRetracted "false" @default.
- W4361949077 workType "article" @default.